Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022)

Historic Depreciation and Depletion for Caribou Biosciences (CRBU) over the last 3 years, with Q2 2022 value amounting to $400000.0.

  • Caribou Biosciences' Depreciation and Depletion rose 10000.0% to $400000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $301000.0, marking a year-over-year decrease of 6655.56%. This contributed to the annual value of $1000.0 for FY2021, which is 9988.89% down from last year.
  • As of Q2 2022, Caribou Biosciences' Depreciation and Depletion stood at $400000.0, which was up 10000.0% from $300000.0 recorded in Q1 2022.
  • In the past 5 years, Caribou Biosciences' Depreciation and Depletion registered a high of $400000.0 during Q2 2022, and its lowest value of -$699000.0 during Q4 2021.
  • Over the past 3 years, Caribou Biosciences' median Depreciation and Depletion value was $200000.0 (recorded in 2020), while the average stood at $155666.7.
  • As far as peak fluctuations go, Caribou Biosciences' Depreciation and Depletion crashed by 44950.0% in 2021, and later surged by 10000.0% in 2022.
  • Quarter analysis of 3 years shows Caribou Biosciences' Depreciation and Depletion stood at $200000.0 in 2020, then plummeted by 449.5% to -$699000.0 in 2021, then surged by 157.22% to $400000.0 in 2022.
  • Its Depreciation and Depletion stands at $400000.0 for Q2 2022, versus $300000.0 for Q1 2022 and -$699000.0 for Q4 2021.